Generics

Lupin intros generic Noxafil
Posaconazole had a market value of roughly $186 million, according to IQVIA December 2020 data.
FDA touts Generic Drug Program’s efforts to ensure supply amid COVID-19
In 2020, the FDA approved or tentatively approved 948 generic drug applications, including 72 first generics. The FDA also approved 30 generics under the Competitive Generic Therapy.

Slayback taps Dave Picard as chief commercial officer

Dave Picard, formerly senior vice president of global generic pharmaceuticals at AmerisourceBergen, is joining Slayback as chief commercial officer.
AAM report: Complex generics could save U.S. healthcare system $1.3B per year

Based on estimates, generic competition in the United States for seven complex products in AAM's analysis would yield annual savings between $600 million and $1.7 billion, with a median savings estimate of $1.3 billion.
Akorn obtains FDA green light for loteprednol etabonate ophthalmic gel

Loteprednol etabonate ophthalmic gel 0.5% had a market value of approximately $35 million for the 12 months ended December 2020, according to IQVIA.
Glenmark gets FDA nod for generic Cleocin T Gel

The Cleocin T Gel had a market value of approximately $73.8 million for the 12 months ended December 2020, according to IQVIA.
Glenmark obtains FDA green light for generic Qudexy

Qudexy XR capsules had a market value of about $120.8 million for the 12 month period endedDecember 2020, according to IQVIA.
Lupin gets FDA nod for generic Kerydin

Tavaborole topical solution had a market value of roughly $76 million, according to IQVIA December 2020 data.
Lannett expands strategic relationship with HEC for biosimilar Aspart

Lannett and HEC will co-develop biosimilar insulin Aspart, with Lannett possessing exclusive U.S. commercialization rights.
Focus On: How Dr. Reddy’s Labs’ approach sets it apart in a crowded space

Officials at Dr. Reddy’s are doing all they can to make sure the company is at the top of the list when retail pharmacists are seeking a business partner in the complicated and unique world of generic drug manufacturing.

Lupin intros generic Noxafil

FDA touts Generic Drug Program’s efforts to ensure supply amid COVID-19

Slayback taps Dave Picard as chief commercial officer

AAM report: Complex generics could save U.S. healthcare system $1.3B per year

Akorn obtains FDA green light for loteprednol etabonate ophthalmic gel

Glenmark gets FDA nod for generic Cleocin T Gel

Glenmark obtains FDA green light for generic Qudexy

Lupin gets FDA nod for generic Kerydin

Lannett expands strategic relationship with HEC for biosimilar Aspart

Focus On: How Dr. Reddy’s Labs’ approach sets it apart in a crowded space